Clínica Universidad de Navarra (CUN)
Centro clínico de la Universidad de Navarra
Hospital Universitario 12 de Octubre
Madrid, EspañaPublications in collaboration with researchers from Hospital Universitario 12 de Octubre (958)
2024
-
A Pilot Study on Proteomic Predictors of Mortality in Stable COPD
Cells, Vol. 13, Núm. 16
-
A Simple Frailty Score Predicts Survival and Early Mortality in Systemic AL Amyloidosis
Cancers, Vol. 16, Núm. 9
-
Acceptability of Long-Acting Injectable Antiretroviral Treatment for HIV Management: Perspectives of Patients and Physicians in Spain
AIDS Patient Care and STDs, Vol. 38, Núm. 7, pp. 305-314
-
Acute kidney disease beyond day 7 after major surgery: a secondary analysis of the EPIS-AKI trial
Intensive Care Medicine, Vol. 50, Núm. 2, pp. 247-257
-
Analysis of Tumor Microenvironment Changes after Neoadjuvant Chemotherapy with or without Bevacizumab in Advanced Ovarian Cancer (GEICO-89T/ MINOVA Study)
Clinical Cancer Research, Vol. 30, Núm. 1, pp. 176-186
-
Atezolizumab Combined with Platinum and Maintenance Niraparib for Recurrent Ovarian Cancer with a Platinum-Free Interval >6 Months: ENGOT-OV41/GEICO 69-O/ANITA Phase III Trial
Journal of Clinical Oncology
-
Biomarkers of Efficacy and Safety of the Academic BCMA-CART ARI0002h for the Treatment of Refractory Multiple Myeloma
Clinical Cancer Research, Vol. 30, Núm. 10, pp. 2085-2096
-
Bridging Metabolic-Associated Steatotic Liver Disease and Cardiovascular Risk: A Potential Role for Ketogenesis
Biomedicines, Vol. 12, Núm. 3
-
CEA-CD3 bispecific antibody cibisatamab with or without atezolizumab in patients with CEA-positive solid tumours: results of two multi-institutional Phase 1 trials
Nature Communications, Vol. 15, Núm. 1
-
COPD: systemic proteomic profiles in frequent and infrequent exacerbators
ERJ Open Research, Vol. 10, Núm. 2
-
Can anticoagulation be withdrawn in APS patients after aPL negativization?
Autoimmunity Reviews, Vol. 23, Núm. 1
-
Cardiac events occurring after allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide. Study conducted on behalf of the GETH-TC
Bone Marrow Transplantation
-
Case–control study assessing the impact of COVID19 in advanced kidney cancer patients treated with antiangiogenics or immunotherapy: the COVID-REN study
Clinical and Translational Oncology, Vol. 26, Núm. 3, pp. 732-738
-
Chromosomal breaks: another differential gap between early-onset and late-onset colorectal cancers
British Journal of Surgery, Vol. 111, Núm. 3
-
Clinical characteristics and prognostic factor in juvenile dermatomyositis: data of the Spanish registry
Pediatric Rheumatology , Vol. 22, Núm. 1
-
Clinical impact of remote heart failure management using the multiparameter ICD HeartLogic alert
Revista Espanola de Cardiologia
-
Consensus guidelines and recommendations for the management and response assessment of chimeric antigen receptor T-cell therapy in clinical practice for relapsed and refractory multiple myeloma: a report from the International Myeloma Working Group Immunotherapy Committee
The Lancet Oncology, Vol. 25, Núm. 8, pp. e374-e387
-
Curative Strategy for High-Risk Smoldering Myeloma: Carfilzomib, Lenalidomide, and Dexamethasone (KRd) Followed by Transplant, KRd Consolidation, and Rd Maintenance
Journal of Clinical Oncology, Vol. 42, Núm. 27, pp. 3247-3256
-
Current landscape of gastrointestinal radiation oncology in Spain: a multicenter real-life survey and comparison with key clinical guidelines
Reports of Practical Oncology and Radiotherapy, Vol. 29, Núm. 3, pp. 340-347
-
Differences in the clinical and hormonal presentation of patients with familial and sporadic primary aldosteronism
Frontiers in Endocrinology, Vol. 15